| Name |
Olynth 1 mg/ml sprej za nos, otopina |
| Marketing Authorisation Number |
HR-H-201840150 |
| Active Substance |
ksilometazolinklorid |
| Composition |
jedan ml spreja za nos, otopine sadrži 1 mg ksilometazolinklorida; jedan potisak (140 µl) sadrži 0,140 mg ksilometazolinklorida |
| Pharmaceutical Form |
sprej za nos, otopina |
| Manufacturer |
Delpharm Orléans, Orleans Cedex 2, Francuska |
| Marketing Authorisation Holder |
McNeil Healthcare (Ireland) Limited, Tallaght, High Street, Office 5, 6 & 7, Block 5, Dublin, Irska |
| Marketing Authorisation Date |
27.12.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/16-02/434 |
| Registration Number |
381-12-01/14-23-20 |
| Prescription |
bez recepta |
| Distribution |
u ljekarni |
| Advertising to general public |
dopušteno |
| ATC Code |
R01AA07 |
| Medicinal product marketed in the Croatia |
Da |
| SmPC |
download |
| PL |
download |
